Stay updated with breaking news from Eric Dobmeier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 1,820,000 shares, a decline of 56.4% from the May 31st total of 4,170,000 shares. Based on an average daily volume of 1,330,000 shares, the […]
William Blair cut shares of Chinook Therapeutics (NASDAQ:KDNY – Get Rating) from an outperform rating to a market perform rating in a report published on Monday morning, The Fly reports. A number of other research analysts also recently issued reports on KDNY. HC Wainwright lifted their price objective on shares of Chinook Therapeutics from $31.00 […]
Guggenheim lowered shares of Chinook Therapeutics (NASDAQ:KDNY – Get Rating) from a buy rating to a neutral rating in a report published on Monday morning, The Fly reports. A number of other equities research analysts have also recently commented on KDNY. Piper Sandler started coverage on shares of Chinook Therapeutics in a research note on […]
Stifel Nicolaus cut shares of Chinook Therapeutics (NASDAQ:KDNY – Get Rating) from a buy rating to a hold rating in a research note published on Tuesday, The Fly reports. Several other research firms have also commented on KDNY. SVB Securities lowered shares of Chinook Therapeutics from an outperform rating to a market perform rating in […]
Chinook Therapeutics (NASDAQ:KDNY – Get Rating) was downgraded by investment analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research note issued on Tuesday, PriceTargets.com reports. Several other brokerages have also recently commented on KDNY. William Blair cut Chinook Therapeutics from an “outperform” rating to a “market perform” rating […]